• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Screening Tool of Older Person's Prescriptions/Screening Tools to Alert Doctors to Right Treatment Medication Criteria Modified for U.S. Nursing Home Setting.老年人处方筛查工具/用于提醒医生正确治疗用药标准的筛查工具(针对美国养老院环境进行了修改)
J Am Geriatr Soc. 2017 Mar;65(3):586-591. doi: 10.1111/jgs.14689. Epub 2016 Dec 23.
2
Potentially inappropriate medications in a sample of Portuguese nursing home residents: Does the choice of screening tools matter?葡萄牙养老院居民样本中潜在不适当用药情况:筛查工具的选择重要吗?
Int J Clin Pharm. 2016 Oct;38(5):1103-11. doi: 10.1007/s11096-016-0337-y. Epub 2016 Jun 24.
3
Application of the STOPP/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact.STOPP/START 标准的应用:老年人潜在不适当处方的流行率的系统评价,以及临床、人文和经济影响的证据。
J Clin Pharm Ther. 2013 Oct;38(5):360-72. doi: 10.1111/jcpt.12059. Epub 2013 Apr 2.
4
GheOP S tool and START/STOPP criteria version 2 for screening of potentially inappropriate medications and omissions in nursing home residents.用于筛查养老院居民潜在不适当用药和遗漏情况的GheOP S工具及START/STOPP标准第2版。
J Eval Clin Pract. 2020 Feb;26(1):158-164. doi: 10.1111/jep.13107. Epub 2019 Feb 5.
5
Medication Appropriateness for Older Nursing Home Patients With a Limited Life Expectancy: From STOPP/START Version 2 to the ReNeWAL Criteria.老年护理院有限预期寿命患者的药物适宜性:从 STOPP/START 版本 2 到 ReNeWAL 标准。
J Am Med Dir Assoc. 2024 Sep;25(9):105143. doi: 10.1016/j.jamda.2024.105143. Epub 2024 Jul 9.
6
The Association Between Potentially Inappropriate Prescribing and Medication-Related Hospital Admissions in Older Patients: A Nested Case Control Study.老年患者潜在不适当处方与药物相关住院之间的关联:一项巢式病例对照研究。
Drug Saf. 2016 Jan;39(1):79-87. doi: 10.1007/s40264-015-0361-1.
7
STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation.老年人处方筛查工具(STOPP)和提醒医生正确治疗的筛查工具(START)。共识验证。
Int J Clin Pharmacol Ther. 2008 Feb;46(2):72-83. doi: 10.5414/cpp46072.
8
Long-Term Outcomes of Medication Intervention Using the Screening Tool of Older Persons Potentially Inappropriate Prescriptions Screening Tool to Alert Doctors to Right Treatment Criteria.使用老年人潜在不适当处方筛查工具进行药物干预的长期结果,以提醒医生正确的治疗标准。
J Am Geriatr Soc. 2017 Feb;65(2):e33-e38. doi: 10.1111/jgs.14570. Epub 2016 Dec 9.
9
'Modified STOPP-START criteria for Sri Lanka'; translating to a resource limited healthcare setting by Delphi consensus.斯里兰卡改良的 STOPP-START 标准;通过德尔菲共识转化为资源有限的医疗保健环境。
BMC Geriatr. 2019 Oct 22;19(1):282. doi: 10.1186/s12877-019-1293-x.
10
The Norwegian General Practice--Nursing Home criteria (NORGEP-NH) for potentially inappropriate medication use: A web-based Delphi study.挪威全科医疗——养老院潜在不适当用药标准(NORGEP-NH):一项基于网络的德尔菲研究。
Scand J Prim Health Care. 2015 Jun;33(2):134-41. doi: 10.3109/02813432.2015.1041833. Epub 2015 Jun 23.

引用本文的文献

1
International Deprescribing Guidelines Did Not Impact Actual Practice in Deprescribing of Potentially Inappropriate Medications for Nursing Home Residents: An Interrupted Time Series Analysis.国际减药指南对疗养院居民潜在不适当药物减药的实际操作未产生影响:一项中断时间序列分析。
Drugs Aging. 2025 May;42(5):485-499. doi: 10.1007/s40266-025-01197-2. Epub 2025 Mar 20.
2
Prevalence and influencing factors of medication-related burden among patients with late-life depression in typical city of eastern China: a cross-sectional study.中国东部典型城市老年抑郁症患者药物相关负担的患病率及影响因素:一项横断面研究
BMC Public Health. 2024 Dec 18;24(1):3521. doi: 10.1186/s12889-024-20939-2.
3
Medication Management in Portuguese Long-Term Care Facilities: A Preliminary Cross-Sectional Study.葡萄牙长期护理机构中的药物管理:一项初步横断面研究。
Healthcare (Basel). 2024 Oct 29;12(21):2145. doi: 10.3390/healthcare12212145.
4
Assessing the feasibility and likelihood of policy options to lower specialty drug costs.评估降低专科药物成本的政策选择的可行性和可能性。
Health Aff Sch. 2024 Sep 27;2(10):qxae118. doi: 10.1093/haschl/qxae118. eCollection 2024 Oct.
5
Potentially inappropriate medication use as predictors of hospitalization for residents in nursing home.潜在不适当药物使用与养老院居民住院的相关性研究。
BMC Geriatr. 2023 Aug 2;23(1):467. doi: 10.1186/s12877-023-04165-w.
6
Prevalence of Potentially Inappropriate Prescriptions According to the New STOPP/START Criteria in Nursing Homes: A Systematic Review.根据新的STOPP/START标准评估养老院潜在不适当处方的患病率:一项系统综述
Healthcare (Basel). 2023 Feb 1;11(3):422. doi: 10.3390/healthcare11030422.
7
Development of a medication review tool for residents in Korean long-term care facilities.为韩国长期护理机构的住院患者开发一种药物审查工具。
Ther Adv Chronic Dis. 2022 Oct 8;13:20406223221128444. doi: 10.1177/20406223221128444. eCollection 2022.
8
Planning and Reporting Effective Web-Based RAND/UCLA Appropriateness Method Panels: Literature Review and Preliminary Recommendations.规划和报告有效的基于网络的 RAND/UCLA 适宜性方法小组:文献回顾和初步建议。
J Med Internet Res. 2022 Aug 26;24(8):e33898. doi: 10.2196/33898.
9
Potentially Inappropriate Medications and Potential Prescribing Omissions in Elderly Patients Receiving Post-Acute and Long-Term Care: Application of Screening Tool of Older People's Prescriptions/Screening Tool to Alert to Right Treatment Criteria.接受急性后期和长期护理的老年患者中潜在不适当用药及潜在处方遗漏情况:老年人处方筛查工具/正确治疗标准警示筛查工具的应用
Front Pharmacol. 2021 Oct 19;12:747523. doi: 10.3389/fphar.2021.747523. eCollection 2021.
10
Potentially Inappropriate Drug Duplication in a Cohort of Older Adults with Dementia.一组老年痴呆症患者中潜在的不适当药物重复使用情况。
Curr Ther Res Clin Exp. 2021 Aug 28;95:100644. doi: 10.1016/j.curtheres.2021.100644. eCollection 2021.

本文引用的文献

1
Acceptability of an online modified Delphi panel approach for developing health services performance measures: results from 3 panels on arthritis research.用于制定卫生服务绩效指标的在线改良德尔菲小组方法的可接受性:来自3个关节炎研究小组的结果
J Eval Clin Pract. 2017 Apr;23(2):354-360. doi: 10.1111/jep.12623. Epub 2016 Sep 13.
2
On using ethical principles of community-engaged research in translational science.论在转化科学中运用社区参与研究的伦理原则。
Transl Res. 2016 May;171:52-62.e1. doi: 10.1016/j.trsl.2015.12.008. Epub 2015 Dec 19.
3
Development of System-level Performance Measures for Evaluation of Models of Care for Inflammatory Arthritis in Canada.加拿大炎症性关节炎照护模式评估的系统层面绩效指标的制定
J Rheumatol. 2016 Mar;43(3):530-40. doi: 10.3899/jrheum.150839. Epub 2016 Jan 15.
4
Development of key performance indicators to evaluate centralized intake for patients with osteoarthritis and rheumatoid arthritis.制定关键绩效指标以评估骨关节炎和类风湿关节炎患者的集中收治情况。
Arthritis Res Ther. 2015 Nov 14;17:322. doi: 10.1186/s13075-015-0843-7.
5
Which Dimensions of Patient-Centeredness Matter? - Results of a Web-Based Expert Delphi Survey.以患者为中心的哪些维度至关重要?——基于网络的专家德尔菲调查结果
PLoS One. 2015 Nov 5;10(11):e0141978. doi: 10.1371/journal.pone.0141978. eCollection 2015.
6
American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults.美国老年医学会2015年更新的《老年人潜在不适当用药的Beers标准》
J Am Geriatr Soc. 2015 Nov;63(11):2227-46. doi: 10.1111/jgs.13702. Epub 2015 Oct 8.
7
Development of Cardiovascular Quality Indicators for Rheumatoid Arthritis: Results from an International Expert Panel Using a Novel Online Process.类风湿关节炎心血管质量指标的制定:采用新型在线流程的国际专家小组研究结果
J Rheumatol. 2015 Sep;42(9):1548-55. doi: 10.3899/jrheum.141603. Epub 2015 Jul 15.
8
STOPP/START criteria for potentially inappropriate prescribing in older people: version 2.老年人潜在不适当处方的STOPP/START标准:第2版
Age Ageing. 2015 Mar;44(2):213-8. doi: 10.1093/ageing/afu145. Epub 2014 Oct 16.
9
Reducing the burden of suicide in the U.S.: the aspirational research goals of the National Action Alliance for Suicide Prevention Research Prioritization Task Force.减轻美国的自杀负担:自杀预防研究优先排序特别工作组国家行动联盟的理想研究目标。
Am J Prev Med. 2014 Sep;47(3):309-14. doi: 10.1016/j.amepre.2014.01.004. Epub 2014 Apr 18.
10
How can we recognize continuous quality improvement?我们如何识别持续质量改进?
Int J Qual Health Care. 2014 Feb;26(1):6-15. doi: 10.1093/intqhc/mzt085. Epub 2013 Dec 4.

老年人处方筛查工具/用于提醒医生正确治疗用药标准的筛查工具(针对美国养老院环境进行了修改)

Screening Tool of Older Person's Prescriptions/Screening Tools to Alert Doctors to Right Treatment Medication Criteria Modified for U.S. Nursing Home Setting.

作者信息

Khodyakov Dmitry, Ochoa Aileen, Olivieri-Mui Brianne L, Bouwmeester Carla, Zarowitz Barbara J, Patel Meenakshi, Ching Diana, Briesacher Becky

机构信息

RAND Corporation and RAND Pardee Graduate School, Santa Monica, California.

School of Pharmacy, Northeastern University, Boston, Massachusetts.

出版信息

J Am Geriatr Soc. 2017 Mar;65(3):586-591. doi: 10.1111/jgs.14689. Epub 2016 Dec 23.

DOI:10.1111/jgs.14689
PMID:28008599
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5370573/
Abstract

OBJECTIVES

To develop a set of prescribing indicators measurable with available data from electronic nursing home (NH) databases by adapting the European-based 2014 Screening Tool of Older Person's Prescriptions (STOPP) and Screening Tools to Alert Doctors to Right Treatment (START) criteria of potentially inappropriate and underused medications for the U.S.

DESIGN

A two-stage expert panel process. In the first stage, the investigator team reviewed 114 criteria for compatibility and measurability. In the second stage, an online modified e-Delphi (OMD) panel was convened to rate the validity of criteria, and two webinars were held to identify criteria with highest relevance to U.S. NHs.

PARTICIPANTS

Seventeen experts with recognized reputations in NH care participated in the e-Delphi panel and 12 in the webinar.

MEASUREMENTS

Compatibility and measurability were assessed by comparing criteria with U.S. terminology and setting standards and data elements in NH databases. Validity was rated using a 9-point Likert-type scale (1 = not valid at all, 9 = highly valid). Mean, median, interpercentile ranges, and agreement were determined for each criterion score. Relevance was determined by ranking the mean panel ratings on criteria that reached agreement; the webinar participants reviewed and approved half of the criteria with the highest mean values.

RESULTS

Fifty-three STOPP/START criteria were deemed to be compatible with the U.S. NH setting and measurable using data from electronic NH databases. E-Delphi panelists rated 48 criteria as valid for U.S. NHs. Twenty-four criteria were deemed to be most relevant, consisting of 22 measures of potentially inappropriate medications and two measures of underused medications.

CONCLUSION

This study created the first explicit criteria for assessing the quality of prescribing in U.S. NHs.

摘要

目的

通过改编基于欧洲的2014年老年人处方筛查工具(STOPP)和提醒医生正确治疗的筛查工具(START)中关于美国潜在不适当和未充分使用药物的标准,制定一套可通过电子养老院(NH)数据库中的现有数据进行测量的处方指标。

设计

两阶段专家小组流程。在第一阶段,研究团队审查了114条标准的兼容性和可测量性。在第二阶段,召开了一个在线改良电子德尔菲(OMD)小组会议对标准的有效性进行评分,并举办了两次网络研讨会以确定与美国养老院最相关的标准。

参与者

17位在养老院护理领域享有公认声誉的专家参加了电子德尔菲小组会议,12位参加了网络研讨会。

测量

通过将标准与美国术语以及养老院数据库中的设定标准和数据元素进行比较来评估兼容性和可测量性。使用9点李克特量表对有效性进行评分(1 = 完全无效,9 = 高度有效)。确定每个标准分数的均值、中位数、百分位数范围和一致性。相关性通过对达成一致的标准的小组平均评分进行排序来确定;网络研讨会参与者审查并批准了均值最高的一半标准。

结果

53条STOPP/START标准被认为与美国养老院环境兼容,并可使用电子养老院数据库中的数据进行测量。电子德尔菲小组成员将48条标准评为对美国养老院有效。24条标准被认为最相关,包括22条潜在不适当药物的测量指标和2条未充分使用药物的测量指标。

结论

本研究创建了首个用于评估美国养老院处方质量的明确标准。